Economic burden of growth hormone deficiency in a US pediatric population

Mostrar otras versiones (1)

BACKGROUND: Pediatric growth hormone deficiency (GHD) is a rare disorder of short stature that is currently treated with daily injections of somatropin. In addition to short stature, GHD is associated with other comorbidities such as impaired musculoskeletal development, cardiovascular disease, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplowitz, Paul, Manjelievskaia, Janna, Lopez-Gonzalez, Lorena, Morrow, Cynthia D, Pitukcheewanont, Pisit, Smith, Alden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394182/
https://www.ncbi.nlm.nih.gov/pubmed/33896224
http://dx.doi.org/10.18553/jmcp.2021.21030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394182/
https://www.ncbi.nlm.nih.gov/pubmed/33896224
http://dx.doi.org/10.18553/jmcp.2021.21030

Ejemplares similares